Paul Alloway serves as Executive at Homology Medicines, Inc., where they oversee executive responsibilities. Since joining the company, Paul Alloway has executed 10 insider transactions totaling $30.8K, demonstrating a bearish approach to their equity position. Their most recent transaction on Mar 25, 2024 involved selling 268 shares valued at $6.5K.
Paul Alloway currently holds 2,596 shares of Homology Medicines, Inc. (FIXX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Paul Alloway has been a net seller of FIXX stock. They have purchased $0 and sold $30.8K worth of shares.
Paul Alloway's most recent insider trade was on Mar 25, 2024, when they sold 268 shares at $24.21 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jan 3, 2024 | FIXX | $4.1K | Sale | 7,280 | $0.57 | Discretionary |
| Jan 1, 2024 | FIXX | $0 | Option Exercise | 8,910 | $N/A | Discretionary |
| Jan 1, 2024 | FIXX | $0 | Option Exercise | 4,420 | $N/A | Discretionary |
| Jan 1, 2024 | FIXX | $0 | Option Exercise | 5,280 | $N/A | Discretionary |
| Mar 2, 2023 | FIXX | $15.9K | Sale | 10,965 | $1.45 | Discretionary |
| Jan 9, 2023 | FIXX | $4.3K | Sale | 3,090 | $1.39 | Discretionary |
| Jan 1, 2023 | FIXX | $0 | Option Exercise | 5,280 | $N/A | Discretionary |
| Jan 1, 2023 | FIXX | $0 | Option Exercise | 4,290 | $N/A | Discretionary |